Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease
2019
Introduction The aim of this study was to evaluate the association between serum
ustekinumab(UST)
trough levelsand response to induction and maintenance UST treatment in refractory
Crohn’s Disease(CD) patients.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
25
References
9
Citations
NaN
KQI